Publications by authors named "Ravi Jandhyala"

17Publications

Delphi, non-RAND modified Delphi, RAND/UCLA appropriateness method and a novel group awareness and consensus methodology for consensus measurement: a systematic literature review.

Authors:
Ravi Jandhyala

Curr Med Res Opin 2020 Nov 15;36(11):1873-1887. Epub 2020 Sep 15.

Medialis Ltd, Banbury, UK.

View Article and Find Full Text PDF
November 2020

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study.

Authors:
Raja Padidela Ola Nilsson Outi Makitie Signe Beck-Nielsen Gema Ariceta Dirk Schnabel Maria Luisa Brandi Annemieke Boot Elena Levtchenko Michael Smyth Ravi Jandhyala Zulf Mughal

Orphanet J Rare Dis 2020 06 30;15(1):172. Epub 2020 Jun 30.

Royal Manchester Children's Hospital and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

View Article and Find Full Text PDF
June 2020

The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus.

Authors:
Sankarasubramanian Rajaram Radek Wojcik Catherine Moore Raúl Ortiz de Lejarazu Simon de Lusignan Emanuele Montomoli Alessandro Rossi Alberto Pérez-Rubio Antoni Trilla Vincenzo Baldo Ravi Jandhyala George Kassianos

Vaccine 2020 08 26;38(38):6047-6056. Epub 2020 Jun 26.

Royal College of General Practitioners, British Global and Travel Health Association, London, UK.

View Article and Find Full Text PDF
August 2020

A novel method for observing proportional group awareness and consensus of items arising from list-generating questioning.

Authors:
Ravi Jandhyala

Curr Med Res Opin 2020 05 11;36(5):883-893. Epub 2020 Mar 11.

Medialis Ltd, Banbury, UK.

View Article and Find Full Text PDF
May 2020

Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.

Authors:
Ravi Jandhyala

Pharmaceut Med 2020 04;34(2):127-134

University of Leicester Business School, Leicester, UK.

View Article and Find Full Text PDF
April 2020

Factors Influencing the Generation of Evidence from Simple Data Held in International Rare Disease Patient Registries.

Authors:
Ravi Jandhyala Solomon Christopher

Pharmaceut Med 2020 02;34(1):31-38

Medialis Ltd, 13 Horse Fair, Banbury, Oxford, OX16 0AH, UK.

View Article and Find Full Text PDF
February 2020

Comment on: "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".

Authors:
Ravi Jandhyala

Drug Saf 2019 12;42(12):1515-1516

Medialis Ltd, Oxford, UK.

View Article and Find Full Text PDF
December 2019

FGF23 and its role in X-linked hypophosphatemia-related morbidity.

Authors:
Signe Sparre Beck-Nielsen Zulf Mughal Dieter Haffner Ola Nilsson Elena Levtchenko Gema Ariceta Carmen de Lucas Collantes Dirk Schnabel Ravi Jandhyala Outi Mäkitie

Orphanet J Rare Dis 2019 02 26;14(1):58. Epub 2019 Feb 26.

Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

View Article and Find Full Text PDF
February 2019

Speaker Publication Profiles from Major Conferences in Aesthetics, Plastic Surgery, and Dermatology.

Authors:
Ravi Jandhyala

J Clin Aesthet Dermatol 2018 Sep 1;11(9):13-18. Epub 2018 Sep 1.

Dr. Jandhyala is with Medialis Ltd. in Banbury, United Kingdom.

View Article and Find Full Text PDF
September 2018

Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

Authors:
Hamish Courtney Rahul Nayar Chinnadorai Rajeswaran Ravi Jandhyala

Diabetes Metab Syndr Obes 2017 13;10:79-87. Epub 2017 Mar 13.

Medical Affairs, Diabetes, AstraZeneca, Luton, UK.

View Article and Find Full Text PDF
March 2017

Authors' reply to Davis.

Authors:
Ravi Jandhyala John R Fullarton Michael I Bennett

J Pain Symptom Manage 2014 Jul 5;48(1):e3-4. Epub 2014 May 5.

University of Leeds, Leeds, West Yorkshire, United Kingdom.

View Article and Find Full Text PDF
July 2014

Impact of botulinum toxin a on the quality of life of subjects following treatment of facial lines.

Authors:
Ravi Jandhyala

J Clin Aesthet Dermatol 2013 Sep;6(9):41-5

The Jandhyala Institute, Banbury, United Kingdom.

View Article and Find Full Text PDF
September 2013

Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.

Authors:
Ravi Jandhyala John R Fullarton Michael I Bennett

J Pain Symptom Manage 2013 Oct 4;46(4):573-80. Epub 2013 Feb 4.

Cephalon UK, Ltd., Welwyn Garden City, Hertfordshire, United Kingdom. Electronic address:

View Article and Find Full Text PDF
October 2013

Improving consent procedures and evaluation of treatment success in cosmetic use of incobotulinumtoxinA: an assessment of the treat-to-goal approach.

Authors:
Ravi Jandhyala

J Drugs Dermatol 2013 Jan;12(1):72-8

The Jandhyala Institute, Banbury, UK.

View Article and Find Full Text PDF
January 2013

Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidence.

Authors:
Ravi Jandhyala

J Drugs Dermatol 2012 Jun;11(6):731-6

Banbury Face Clinic, The Jandhyala Institute, Banbury, UK.

View Article and Find Full Text PDF
June 2012

Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis.

Authors:
Ravi Jandhyala John Fullarton

BMJ Support Palliat Care 2012 Jun;2(2):156-62

Cephalon UK, Welwyn Garden City, UK.

View Article and Find Full Text PDF
June 2012

Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.

Authors:
Ravi Jandhyala

J Plast Reconstr Aesthet Surg 2012 Jun 4;65(6):720-31. Epub 2012 Jan 4.

The Jandhyala Institute, Parnassus, Main Street, Great Bourton, Banbury, Oxfordshire, OX171QW, UK.

View Article and Find Full Text PDF
June 2012